| FSI | PRESS-RELEASE | bearish | 7/10 | Flexible Solutions reported a weak Q2 2026 with revenue of $7.6M, down ~14% YoY, and a GAAP net loss of ($0.15) per shar | Aug 14, 2026 |
| SIDU | PRESS-RELEASE | mixed | 6/10 | Sidus Space reported Q2 2026 revenue of $583K, down 54% YoY, with a net loss improvement of 15% to -$4.8M. The company s | Aug 14, 2026 |
| DSX | PRESS-RELEASE | bearish | 6/10 | Diana Shipping (DSX) has withdrawn its offer to acquire Genco Shipping (GNK) after the Genco Board demanded consideratio | Aug 14, 2026 |
| CUE | PRESS-RELEASE | neutral | 4/10 | Cue Biopharma reported Q2 2026 net loss of $153.1M on revenue of $7.9M, well above consensus estimates on both lines, bu | Aug 14, 2026 |
| FEMY | PRESS-RELEASE | mixed | 5/10 | Femasys reported Q2 2026 revenue of $331,827, down 18.9% YoY, with a net loss of $4.47M ($1.33/share). The EPS beat cons | Aug 14, 2026 |
| AMBO | PRESS-RELEASE | bearish | 6/10 | Ambow Education reported a weak Q2 2026 with net revenues declining 14.3% YoY to $2.4M and swinging to a net loss of $0. | Aug 14, 2026 |
| PARA | PRESS-RELEASE | bearish | 7/10 | Banzai International (PARA) reported Q2 2026 revenue of $2.3M (-27.3% YoY) and a GAAP net loss of $5.0M, versus consensu | Aug 14, 2026 |
| PSIG | PRESS-RELEASE | bearish | 7/10 | PS International Group received a Nasdaq deficiency letter for failing to meet the $35M minimum Market Value of Listed S | Aug 14, 2026 |
| EBON | PRESS-RELEASE | neutral | 4/10 | Ebang reported unaudited first-half 2026 results: total net revenues rose 9.54% YoY to $3.92 million and gross profit sw | Aug 14, 2026 |
| MBUU | PRESS-RELEASE | neutral | 1/10 | Malibu Boats, Inc. announced it will report its fiscal Q4 2026 and full-year results on August 27, 2026. | Aug 14, 2026 |
| HYFM | PRESS-RELEASE | bearish | 7/10 | Hydrofarm's Q2 2026 net sales fell 40.9% YoY to $23.2M, the steepest decline in recent quarters, driven by continued ind | Aug 14, 2026 |
| MSGM | PRESS-RELEASE | mixed | 6/10 | Motorsport Games reported Q2 2026 revenue of $3.5M (+36.6% YoY) and GAAP EPS of $0.08, beating the $0.02 consensus by 25 | Aug 14, 2026 |
| CNSY | PRESS-RELEASE | bearish | 6/10 | Cerenome reported a Q2 2026 net loss of $9.0M ($1.31/share), significantly worse than Q2 2025 net income of $5.2M ($0.62 | Aug 14, 2026 |
| GNLN | PRESS-RELEASE | bearish | 7/10 | Greenlane Holdings reported Q2 2026 results showing a net loss of $24.8M, driven by a $19.1M non-cash fair value decline | Aug 14, 2026 |
| BRFH | PRESS-RELEASE | bearish | 7/10 | Barfresh Food Group reported Q2 2026 revenue of $4.7M (up 190% YoY, driven by the Arps Dairy acquisition) but a net loss | Aug 14, 2026 |
| FRSX | PRESS-RELEASE | bearish | 6/10 | Foresight reported Q2 2026 revenue of $86K (down 32.8% YoY from $128K) and a GAAP net loss of $2.8M, roughly flat YoY. T | Aug 14, 2026 |
| UAVS | PRESS-RELEASE | mixed | 5/10 | AgEagle Aerial Systems (UAVS) reported Q2 2026 revenue of $2.7M, up 93% sequentially from $1.4M in Q1 2026, but down 34% | Aug 14, 2026 |
| FIEE | PRESS-RELEASE | bullish | 6/10 | FiEE reported Q2 2026 revenue of $4.8M (vs $0.04M a year ago) and net income of $2.1M, a sharp turnaround from a $0.6M l | Aug 14, 2026 |
| SXTP | PRESS-RELEASE | bearish | 5/10 | Sixty Degrees Pharmaceuticals reported Q2 2026 revenue of $208K (up 106% YoY) but a net loss of $2.40M ($0.90/share), mi | Aug 14, 2026 |
| HCWB | PRESS-RELEASE | bearish | 8/10 | HCW Biologics reported Q1 2026 EPS of $2.22, a 212.1% beat vs the -$1.98 consensus, but this is entirely due to a previo | Aug 14, 2026 |
| PNRG | PRESS-RELEASE | bullish | 6/10 | PrimeEnergy reported Q2 2026 net income of $6.5M ($4.06/share), doubling from $3.2M ($1.94/share) in Q2 2025, driven by | Aug 14, 2026 |
| MMM | PRESS-RELEASE | neutral | 4/10 | 3M reported Q2 2026 EPS of $2.40, a modest 0.3% beat vs consensus of $2.39, with no revenue figure provided in the filin | Aug 14, 2026 |
| AEE | PRESS-RELEASE | neutral | 2/10 | Ameren Corporation declared a regular quarterly cash dividend of $0.75 per common share, unchanged from the prior quarte | Aug 14, 2026 |
| JSPR | PRESS-RELEASE | neutral | 5/10 | Jasper Therapeutics reported Q2 2026 EPS of -$0.10, a 94.3% beat vs the -$1.74 year-ago loss, but this is largely a mech | Aug 14, 2026 |
| SKYE | PRESS-RELEASE | bearish | 7/10 | Skye Bioscience announces a reverse merger with private UK biotech Redx Pharma, forming Fibrx Therapeutics focused on fi | Aug 14, 2026 |
| ELAB | PRESS-RELEASE | neutral | 3/10 | PMGC Holdings (ELAB) reported Q2 2026 revenue of approximately $1.31M, up from $0 in the prior-year period and 92% seque | Aug 14, 2026 |
| LFWD | PRESS-RELEASE | bearish | 6/10 | Lifeward reported Q2 2026 revenue of $6.6M (+16% YoY), slightly above consensus, but GAAP EPS of -$4.12 missed the -$1.2 | Aug 14, 2026 |
| RIME | PRESS-RELEASE | bullish | 5/10 | Algorhythm Holdings (RIME) reported Q2 2026 revenue of $3.0M (+161% YoY, +25% sequential) and GAAP EPS of -$0.25, beatin | Aug 14, 2026 |
| CYAB | PRESS-RELEASE | neutral | 2/10 | Cyabra announced that CEO Dan Brahmy and CFO Yael Sandler will present and host one-on-one investor meetings at Sidoti's | Aug 14, 2026 |
| APWC | PRESS-RELEASE | bearish | 5/10 | APWC reported Q2 FY2026 revenue of $136.6M (+8% YoY) and EPS of $0.01, down 67% YoY due to a 100% increase in weighted a | Aug 14, 2026 |